A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Not all companies are created equal, and StockStory is here to surface the ones with real upside. Keeping that in mind, here is one cash-producing company that reinvests wisely to drive long-term success and two best left off your watchlist.
Two Stocks to Sell:
Domino's (DPZ)
Trailing 12-Month Free Cash Flow Margin: 13.1%
Founded by two brothers in Michigan, Domino’s (NASDAQ: DPZ) is a globally recognized pizza chain known for its creative marketing and fast delivery.
Why Are We Wary of DPZ?
- Sales trends were unexciting over the last seven years as its 5.2% annual growth was below the typical restaurant company
- Estimated sales growth of 5.9% for the next 12 months is soft and implies weaker demand
At $301.34 per share, Domino's trades at 15.3x forward P/E. To fully understand why you should be careful with DPZ, check out our full research report (it’s free).
IDEX (IEX)
Trailing 12-Month Free Cash Flow Margin: 17.3%
Founded in 1988, IDEX (NYSE: IEX) is a global manufacturer specializing in highly engineered products such as pumps, flow meters, and fluidics systems for various industries.
Why Does IEX Give Us Pause?
- Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
- Earnings growth over the last two years fell short of the peer group average as its EPS only increased by 1.2% annually
- Eroding returns on capital suggest its historical profit centers are aging
IDEX is trading at $219.73 per share, or 25.2x forward P/E. Read our free research report to see why you should think twice about including IEX in your portfolio.
One Stock to Buy:
Natera (NTRA)
Trailing 12-Month Free Cash Flow Margin: 4.2%
Founded in 2003 as Gene Security Network before rebranding in 2012, Natera (NASDAQ: NTRA) develops and commercializes genetic tests for prenatal screening, cancer detection, and organ transplant monitoring using its proprietary cell-free DNA technology.
Why Are We Bullish on NTRA?
- Products are seeing elevated demand as its tests processed averaged 19.4% growth over the past two years
- Adjusted operating margin expanded by 15.7 percentage points over the last two years as it scaled and became more efficient
- Free cash flow turned positive over the last five years, showing the company is at an important crossroads
Natera’s stock price of $282.05 implies a valuation ratio of 13.4x forward price-to-sales. Is now the right time to buy? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
